BioWorld

May 5, 1998

View Archived Issues

Genentech Submits BLA For Herceptin Therapy

Read More

Celtrix's Burn Drug Positive In Early Phase II Results

Read More

NitroMed Raises $12M For Enhancer Compounds

Read More

Other News To Note

Read More

Emisphere Raises $13.5M; Plans Oral Heparin Phase II

Read More

Mystery Dystrophy Yields Guilty Secret Of Stuttering Triplet Pile-Up In Cell Nuc

Read More

EntreMed Stock Skyrockets On Cancer Drug Reports

Read More

Isis Chooses Loan To Raise $15M For Antisense Drugs

Read More